ERBB2 and cancer: The saDNA vaccines have demonstrated broad efficacy in models of Infectious diseases (Zika, Ebola, SARS-CoV-2, and rabies), several cancers (e.g., HPV, NY-ESO-1, and HER2), and biodefense targets (anthrax toxins) (listed in Table 2).